DIAN DIAGNOSTICS(SZ:300244) Xin Lang Cai Jing·2026-01-08 03:33Group 1 - The core viewpoint of the news is that Dian Diagnostics has seen a stock price increase of 5.08%, reaching 18.01 CNY per share, with a trading volume of 397 million CNY and a turnover rate of 4.50%, resulting in a total market capitalization of 11.256 billion CNY [1] - Dian Diagnostics, established on September 5, 2001, and listed on July 19, 2011, is based in Hangzhou, Zhejiang Province. The company specializes in providing medical diagnostic service outsourcing solutions to various healthcare institutions, including hospitals, community health service centers, and disease prevention and control centers [1] - The revenue composition of Dian Diagnostics is primarily from channel products (65.34%) and diagnostic services (34.66%) [1] Group 2 - From the perspective of the top ten circulating shareholders, Southern Fund has a fund that ranks among them. The Southern CSI 1000 ETF (512100) reduced its holdings by 40,900 shares in the third quarter, now holding 4.5688 million shares, which accounts for 0.91% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 76.63 billion CNY. Year-to-date, it has achieved a return of 4.1%, ranking 2067 out of 5493 in its category; over the past year, it has returned 40.84%, ranking 1761 out of 4197; and since inception, it has returned 19.06% [2]